European Union Drug Regulating Authorities Clinical Trials Database [EudraCT] registration no
Semaglutide with a 10mg strength is a long-acting GLP-1 analog that has been investigated across multiple biological systems relevant to metabolic research

Contact your healthcare provider if you experience: Absent periods (amenorrhea): Missing three or more consecutive menstrual cycles if previously regular, or six or more months if previously irregular Heavy bleeding (menorrhagia): Soaking through a pad or tampon every hour for several consecutive hours, or periods lasting longer than seven days Severe pain: New or worsening menstrual cramping not relieved by over-the-counter medications Intermenstrual bleeding: Bleeding or spotting between periods that persists beyond initial treatment months Pregnancy possibility: Any missed period when pregnancy is possible, as tirzepatide is not recommended during pregnancy Urgent warning signs: Heavy bleeding with dizziness, fainting, rapid heartbeat, or severe weakness requires emergency evaluation Your healthcare provider may recommend specific investigations to evaluate persistent menstrual irregularities

Reducing Risk of Weight-Related Health Conditions Significant weight loss with Semaglutide can prevent or improve numerous health conditions
together they address overlapping stages of healing
In: Kyle DJ, Osmond CB, Arntzen CJ (eds) Photoinhibition